Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 102Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Melinta Therapeutics

02 2Menarini

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

FNCE
Not Confirmed
arrow
arrow
FNCE
Not Confirmed

ORITAVANCIN DIPHOSPHATE

Brand Name : ORBACTIV

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 400MG BASE/VIAL

Packaging :

Approval Date : 2014-08-06

Application Number : 206334

Regulatory Info : RX

Registration Country : USA

blank

02

FNCE
Not Confirmed
arrow
arrow
FNCE
Not Confirmed

ORITAVANCIN DIPHOSPHATE

Brand Name : KIMYRSA

Dosage Form : POWDER;INTRAVENOUS

Dosage Strength : EQ 1.2GM BASE/VIAL

Packaging :

Approval Date : 2021-03-12

Application Number : 214155

Regulatory Info : RX

Registration Country : USA

blank

03

FNCE
Not Confirmed
arrow
arrow
FNCE
Not Confirmed

Oritavancin Diphosphate

Brand Name : Tenkasi

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 400MG

Packaging :

Approval Date : 2021-05-25

Application Number : 115989001

Regulatory Info : Authorized

Registration Country : Spain

blank

04

FNCE
Not Confirmed
arrow
arrow
FNCE
Not Confirmed

Oritavancin Diphosphate

Brand Name : Tenkasi

Dosage Form : Powder For Concentrate For Infusion Solution

Dosage Strength : 1200MG

Packaging :

Approval Date : 2023-12-05

Application Number : 115989002

Regulatory Info : Authorized

Registration Country : Spain

blank